Your browser doesn't support javascript.
loading
Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort.
Kullmann, Friederike; Strissel, Pamela L; Strick, Reiner; Stoehr, Robert; Eckstein, Markus; Bertz, Simone; Wullich, Bernd; Sikic, Danijel; Wach, Sven; Taubert, Helge; Olbert, Peter; Heers, Hendrik; Lara, María Fernanda; Macias, Maria Luisa; Matas-Rico, Elisa; Lozano, Maria José; Prieto, Daniel; Hierro, Isabel; van Doeveren, Thomas; Bieche, Ivan; Masliah-Planchon, Julien; Beaurepere, Romane; Boormans, Joost L; Allory, Yves; Herrera-Imbroda, Bernardo; Hartmann, Arndt; Weyerer, Veronika.
Afiliação
  • Kullmann F; Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Strissel PL; Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Strick R; Laboratory for Molecular Medicine, Department of Gynecology and Obstetrics, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Stoehr R; Laboratory for Molecular Medicine, Department of Gynecology and Obstetrics, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Eckstein M; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
  • Bertz S; Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Wullich B; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
  • Sikic D; Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Wach S; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
  • Taubert H; Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Olbert P; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
  • Heers H; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
  • Lara MF; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Macias ML; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
  • Matas-Rico E; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Lozano MJ; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
  • Prieto D; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Hierro I; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
  • van Doeveren T; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Bieche I; Privatklinik Brixsana, Urology, Brixen, Italy.
  • Masliah-Planchon J; Department of Urology and Pediatric Urology, University Hospital Gießen and Marburg, Marburg, Germany.
  • Beaurepere R; Department of Urology, Virgen de la Victoria University Hospital Málaga, Instituto de Investigación Biomédica de Málaga, Málaga, Spain.
  • Boormans JL; Genitourinary Cancer Translational Research Group, Instituto de Investigación Biomédica de Málaga, Málaga, Spain.
  • Allory Y; Genitourinary Cancer Translational Research Group, Instituto de Investigación Biomédica de Málaga, Málaga, Spain.
  • Herrera-Imbroda B; Genitourinary Cancer Translational Research Group, Instituto de Investigación Biomédica de Málaga, Málaga, Spain.
  • Hartmann A; Department of Cell Biology, Genetics and Physiology, Málaga University, Málaga, Spain.
  • Weyerer V; Department of Pathology, Faculty of Medicine, Universidad de Málaga, Málaga, Spain.
J Clin Pathol ; 76(2): 126-132, 2023 Feb.
Article em En | MEDLINE | ID: mdl-34583948
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Neoplasias Colorretais / Neoplasias Colorretais Hereditárias sem Polipose Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Neoplasias Colorretais / Neoplasias Colorretais Hereditárias sem Polipose Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article